A retrospective study on the efficacy of corticosteroid-alone therapy in membranous nephropathy patients

Internal Medicine

Volumn 46, Issue 19, 2007, Pages 1641-1645

  Kimura, Moritsugu ^a   Toyoda, Masao ^a   Kobayashi, Keiko ^a   Abe, Makiko ^a   Kobayashi, Takako ^a   Kato, Mayuko ^a   Miyauchi, Masaaki ^a   Yamamoto, Naoyuki ^a   Maruyama, Mayumi ^a   Umezono, Tomoya ^a   Nishina, Makoto ^a   Yagame, Mitsunori ^a   Endo, Masayuki ^a   Suzuki, Daisuke ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Complete remission; Incomplete remission; Moderate proteinuria; No response; Non steroid group; Steroid group

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIET THERAPY; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LABORATORY TEST; LONG TERM CARE; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MONOTHERAPY; PROTEINURIA; REMISSION; REST; RETROSPECTIVE STUDY; DOSE RESPONSE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ADULT; AGED; COMBINED MODALITY THERAPY; DIET THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; MALE; MIDDLE AGED; PROTEINURIA; REMISSION INDUCTION; REST; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 35448965553     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.46.6336     Document Type: Article

References (20)

1. Honkanen E, Törnroth T, Grönhagen-Riska C. Natural history, clinical course and morphological evolution of membranous nephropathy. Nephrol Dial Transplant (Suppl 1): 35-41, 1992.
2. Abe S, Amagasaki Y, Konishi K, Kato E, Iyori S, Sakaguchi H. Idiopathic membranous glomerulonephritis: aspects of geographical differences. J Clin Pathol 39: 1193-1198, 1986.
3. Kida H, Asamoto T, Yokoyama H, Tomosugi N, Hattori N. Longterm prognosis of membranous nephropathy. Clin Nephrol 25: 64-69, 1986.
4. Shiiki H, Saito T, Nishitani Y, et al. Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney Int 65: 1400-1407, 2004.
5. Davison AM, Cameron JS, Kerr DNS, Ogg CS, Wilkinson RW. The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults. Clin Nephrol 22: 61-67, 1984.
6. Marx BE, Marx M. Prediction in idiopathic membranous nephropathy. Kidney Int 56: 666-673, 1999.
7. Bolton W, Atuk NO, Sturgill BC, Westervelt FB. Therapy of the idiopathic nephrotic syndrome with alternate day steroids. Am J Med 62: 60-70, 1977.
8. Hopper J, Trew PA, Biava CG, Membranous nephropathy: Its relative benignity in women. 29: 18-24, 1981.
9. Short CD, Solomon LR, Gokal R, Mallick NP. Methylprednisolone in patients with membranous nephropathy and declining renal function. Q J Med 65: 929-940, 1987.
10. Ponticelli C, Zucchelli P, Passerini P, Cesana B. The Italian idiopathic membranous nephropathy treatment study group. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. N Engl J Med 327: 599-603, 1992.
11. Zucchelli P, Ponticelli C, Cagnoli L, Passerini P. Long term outcome of idiopathic membranous nephropathy with nephritic, syndrome. Nephrol Dial Transplant 2: 73-78, 1987.
12. Cameron JS, Healy MJR, Adu D. The medical research council-trial of short-term high-dose alternate day prednisolone in idiopathic: membranous nephropathy with nephritic syndrome in adults. Q J Med 74: 133-156, 1990.
13. Cattran DC, Delmore T, Roscoe J, et al. A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy. N Engl J Med 320: 210-215, 1989.
14. Tang S, Chan TM, Cheng IKP, Lai KN. Clinical features and treatment outcome of idiopathic membranous nephropathy in Chinese patients. Q J Med 92: 401-406, 1999.
15. Sims S, Rotellar C. Therapy of membranous nephropathy: use of low-protein diet. J Am Soc Nephrol 6: 136-137, 1995.
16. Schieppati A, Ruggenenti P, Perna A, Remuzzi G. Nonimmunosuppressive therapy of membranous nephropathy. Semin Nephrol 23: 333-339, 2003.
17. Funabiki K, Tomino, Y, Shirato I, Yoshida M, Koide H. Increased remission of early stage membranous nephropathy on long-term treatment with corticosteroid. Nippon Jinzo, Gakkai Shi 34: 997-1001, 1992 (in Japanese).
18. Ponticelli C, Passerini P. Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults. Clin Nephrol 35(Suppl 1): S16-S21, 1991.
19. Ponticelli C, Zucchelli P, Passerini P, et al. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int 48: 1600-1604, 1995.
20. Cattran DC, Appel GB, Hebert LA, et al. Cyclosporine in patients, with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int 59: 1484-1490, 2001.